Altimmune, Inc.·4

Jun 19, 4:01 PM ET

Tasker Sybil 4

4 · Altimmune, Inc. · Filed Jun 19, 2019

Insider Transaction Report

Form 4
Period: 2019-06-17
Tasker Sybil
Chief Medical Officer
Transactions
  • Award

    Stock Options (option to buy)

    2019-06-17+20,00020,000 total
    Exercise: $2.46Exp: 2024-06-17Common Stock, par value $0.0001 (20,000 underlying)
Footnotes (1)
  • [F1]100% of the shares will vest in 6 equal monthly installments, with the first vesting date on July 31, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION